Mutant of HIV-1 with deletions between SphI and SalI of pNL4-3, resulting in a frameshift in the gag gene; TAG stop codon inserted in gp41, truncating the endodomain
LCMV Clone 13 expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein Y72F mutatio
LCMV Clone 13 expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein V71S mutatio
LCMV Armstrong expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein V71S mutati
LCMV Clone 13 expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain
LCMV Armstrong expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain
Access to the BSL-3 facility including equipment and personal protective equipment, theoretical and practical training; preparation and evaluation of the BSL-3 work; BSL-3 virus collection as predefined within the project of the end user; personal support for performing specifically designed experiments; expert supervision.
